|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Aarey Drugs & Pharmaceuticals Ltd.
Main Activities: Chemical Manufacturing - Health and Personal Care Stores
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Aarey Drugs & Pharmaceuticals Ltd. Headquarters 107, Sahakar Bhavan,, 340/348, Narsi Natha Street; Mumbai; Maharashtra; 400009 Legal Address E-34, MIDC, , Tarapur, Boisar; Thane; Maharashtra; 401506 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : INE198H01019 Financial Auditors: DMKH & Co (2012) Incorporation Date: May 15, 1990 Tel: 2271049/ 2272313/ |
|
Company Description |
| The privately owned company was set up in 1990, to manufacture trimethoprim and quinoline series of pharmaceutical products. The company made its IPO in December 1993 to part finance its metronidazole manufacturing project. The company was referred to |
Company Analysis |
| According to the Individual - Audited financial statement for the Year of 2012, total net operating revenues increased with 89.06%, from INR 69.09 tens of millions to INR 130.62 tens of millions. Operating result increased from INR 1.56 tens of millions to INR 1.62 tens of millions which means 3.85% change. The results of the period decreased -61.64% reaching INR 0.28 tens of millions at the end of the period against INR 0.73 tens of millions last year. Return on equity (Net income/Total equity) went from 0.00% to 0.85%, the Return On Asset (Net income / Total Asset) went from 2.90% to 1.36% and the Net Profit Margin (Net Income/Net Sales) went from 1.06% to 0.21% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 13.50% compared to 0.00% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 2.13 to 1.32 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2013 Q3C (non-cons) |
2013 H1 (non-cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| Dion Global Solutions - AsianCERC | Dion Global Solutions - AsianCERC | |
| ||
| Unit | Tens of Millions) | Tens of Millions |
| ||
Balance Sheet
| ||
Shareholders Equity |
16 |
16 |
| ||
| * All the accounts are in INR. | ||
Income Statement
| ||
Total Operating Revenue |
123 |
74 |
| ||
Operational Profit (Loss) |
1 |
1 |
| ||
Net Profit (Loss) |
1 |
0 |
| ||
| * All the accounts are in INR. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Equity (ROE) |
7.14% |
5.41% |
| ||
Annualised Return on Equity (ROE) |
9.52% |
10.82% |
| ||
Return on Sales (ROS) |
100% |
100% |
| ||
 |